Proscia touts AI pathology research results

By staff writers

February 25, 2020 -- Artificial intelligence (AI) digital pathology software firm Proscia is highlighting findings from a study published February 21 in Scientific Reports that demonstrates AI's effectiveness in pathology applications.

The study used Proscia's deep-learning system, DermAI, which was developed using images from the Dermatopathology Laboratory of Central States and tested on a set of 13,537 images from Cockerell Dermatopathology, Thomas Jefferson University Hospital, and the University of Florida. The system achieved 98% accuracy in classifying whole slide images of skin biopsies in laboratory settings, Proscia said.

DermAI is the first in a series of AI applications on Proscia's Concentriq platform, and it is currently for research use only, according to the firm.

Proscia thinks big with Dell in digital pathology
Proscia announced a collaboration with Dell Technologies on the expanded version of its Concentriq digital pathology software platform that it said will...
Artificial intelligence takes root in pathology
Artificial intelligence -- the simulation of human intelligence processes by software -- is reaching commercial pathology labs and has begun to significantly...
Smaller labs eye digital pathology options to improve workflow
As workloads increase in laboratory medicine, some pathology labs have considered harnessing new technologies to improve workflow and efficiency. One...

Copyright © 2020

Last Updated np 2/25/2020 3:55:32 PM